Braveheart Bio BRVE
$20.39 +$1.12 (+5.81%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $20.39 0.00%
Open$19.29
Prev close$19.27
Day range$18.83 – $21.16
Volume866.7K
Market cap$1.83B
P/E (TTM)–
Dividend yield–
BRVE Stock News
Headlines matching Braveheart Bio or the BRVE ticker, most recent first.
- Goldman Sachs Remains a Buy on Braveheart Bio, Inc. (BRVE)
- Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $48
- Analysts Offer Insights on NA Companies: IMAX (IMAX) and Braveheart Bio, Inc. (BRVE)
- Analysts Offer Insights on NA Companies: Braveheart Bio, Inc. (BRVE) and TeraWulf Inc (WULF)
- A Quick Look at Today's Ratings for Braveheart Bio(BRVE.US), With a Forecast Between $40 to $48
- Goldman Sachs Maintains Braveheart Bio(BRVE.US) With Buy Rating, Raises Target Price to $49 Positive
- Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45
- Braveheart Bio, Inc. (BRVE) Receives a Buy From Cantor Fitzgerald
- Cantor Fitzgerald Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $40
- Stifel Nicolaus Remains a Buy on Braveheart Bio, Inc. (BRVE)
- Stifel Maintains Braveheart Bio(BRVE.US) With Buy Rating, Maintains Target Price $45
No comments yet — be the first to weigh in on BRVE.
Sign in to join the discussion.